Published in J Rheumatol on January 28, 2010
Strong predictive value of mannose-binding lectin levels for cardiovascular risk of hemodialysis patients. J Transl Med (2016) 1.40
Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry. Rheumatology (Oxford) (2010) 1.25
Cardiovascular involvement in autoimmune diseases. Biomed Res Int (2014) 0.82
Mannan-binding lectin in cardiovascular disease. Biomed Res Int (2014) 0.81
If there is an evolutionary selection pressure for the high frequency of MBL2 polymorphisms, what is it? Clin Exp Immunol (2014) 0.79
Mannose binding lectin and susceptibility to rheumatoid arthritis in Brazilian patients and their relatives. PLoS One (2014) 0.79
Accelerated atherosclerosis in rheumatoid arthritis: rationale for mannose-binding lectins? J Rheumatol (2010) 0.77
Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum (2003) 3.79
Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med (2004) 2.62
Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation (2006) 2.58
Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther (2006) 2.18
Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol (2006) 2.14
Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res (Hoboken) (2010) 1.89
Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. Arthritis Rheum (2007) 1.70
Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol (2003) 1.66
Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals. Circ Cardiovasc Qual Outcomes (2010) 1.56
Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature. Proc Natl Acad Sci U S A (2009) 1.53
Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet (2005) 1.50
Complement plays a central role in Candida albicans-induced cytokine production by human PBMCs. Eur J Immunol (2012) 1.50
Magnetic resonance imaging of wrist and finger joints in healthy subjects occasionally shows changes resembling erosions and synovitis as seen in rheumatoid arthritis. Arthritis Rheum (2004) 1.49
Mannose-binding lectin variant alleles and HLA-DR4 alleles are associated with giant cell arteritis. J Rheumatol (2002) 1.48
[Fibromyalgia, diagnosis and prevalence. Are gender differences explainable?]. Ugeskr Laeger (2009) 1.48
Validity of rheumatoid arthritis diagnoses in the Danish National Patient Registry. Eur J Epidemiol (2004) 1.48
Low mannose-binding lectin serum levels are associated with reduced kidney graft survival. Kidney Int (2012) 1.48
Multiple inflammatory markers in patients with significant coronary artery disease. Int J Cardiol (2006) 1.45
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis (2014) 1.45
Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J Biol Chem (2004) 1.40
A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol (2005) 1.36
Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Arthritis Rheum (2007) 1.36
Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis (2003) 1.32
Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition. J Biol Chem (2009) 1.29
Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum (2013) 1.28
Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. Arthritis Rheum (2012) 1.25
Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. N Engl J Med (2009) 1.24
Characterization of a polymorphism in the coding sequence of FCN3 resulting in a Ficolin-3 (Hakata antigen) deficiency state. Mol Immunol (2008) 1.23
Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol Immunol (2006) 1.23
A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation. J Biol Chem (2010) 1.23
Socioeconomic status and risk of rheumatoid arthritis: a Danish case-control study. J Rheumatol (2006) 1.23
Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen). Mol Immunol (2007) 1.19
The innate pattern recognition molecule Ficolin-1 is secreted by monocytes/macrophages and is circulating in human plasma. Mol Immunol (2008) 1.18
Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes. Mol Immunol (2005) 1.18
Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol (2004) 1.15
Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns. Mol Immunol (2008) 1.13
Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients. J Infect Dis (2002) 1.13
Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum (2011) 1.13
The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidemiol Drug Saf (2008) 1.12
Mini-review: A pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol (2004) 1.11
Molecular organization of human Ficolin-2. Mol Immunol (2006) 1.11
The non-phagocytic route of collagen uptake: a distinct degradation pathway. J Biol Chem (2011) 1.09
Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome. PLoS One (2013) 1.08
Influence of candidate susceptibility genes on tuberculosis in a high endemic region. Mol Immunol (2006) 1.08
A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system. J Immunol (2012) 1.07
Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases. J Rheumatol (2009) 1.07
Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease. Cancer Immunol Immunother (2014) 1.06
The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum (2007) 1.05
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Ann Rheum Dis (2010) 1.04
Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation (2002) 1.03
Natural resistance-associated macrophage protein 1 polymorphisms are associated with microscopy-positive tuberculosis. J Infect Dis (2002) 1.03
Staphylococcal proteases aid in evasion of the human complement system. J Innate Immun (2013) 1.02
Interactions of the humoral pattern recognition molecule PTX3 with the complement system. Immunobiology (2012) 1.02
Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study. Ann Rheum Dis (2013) 1.01
Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Crit Care (2008) 1.00
Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2009) 0.99
Complement-mediated neutralization of dengue virus requires mannose-binding lectin. MBio (2011) 0.97
Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP. J Leukoc Biol (2009) 0.97
Ficolin-1-PTX3 complex formation promotes clearance of altered self-cells and modulates IL-8 production. J Immunol (2013) 0.97
Collectin-11/MASP complex formation triggers activation of the lectin complement pathway--the fifth lectin pathway initiation complex. J Innate Immun (2012) 0.96
Functional analysis of Ficolin-3 mediated complement activation. PLoS One (2010) 0.96
Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system. J Biol Chem (2010) 0.96
Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. Hum Mol Genet (2007) 0.95
Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis. Mol Immunol (2005) 0.95
High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort. Arthritis Rheum (2011) 0.94
N965S is a common ABCA4 variant in Stargardt-related retinopathies in the Danish population. Mol Vis (2007) 0.94
Serum levels of ficolin-3 (Hakata antigen) in patients with systemic lupus erythematosus. J Rheumatol (2009) 0.93
Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study. J Cyst Fibros (2006) 0.92
The 'involution' of mannose-binding lectin. Hum Mol Genet (2005) 0.92
High rate of early restenosis after carotid eversion endarterectomy in homozygous carriers of the normal mannose-binding lectin genotype. Stroke (2005) 0.92
Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis. Circulation (2012) 0.92
Tethering of Ficolin-1 to cell surfaces through recognition of sialic acid by the fibrinogen-like domain. J Leukoc Biol (2010) 0.91
Combination of autoantibodies against different histone proteins influences complement-dependent phagocytosis of necrotic cell material by polymorphonuclear leukocytes in systemic lupus erythematosus. J Rheumatol (2012) 0.91
Double role of mannose-binding lectin in relation to carotid intima-media thickness in patients with rheumatoid arthritis. Mol Immunol (2009) 0.90
Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP. Ann Rheum Dis (2012) 0.90
Unique protein signature of circulating microparticles in systemic lupus erythematosus. Arthritis Rheum (2013) 0.90
The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification. Mol Immunol (2009) 0.90
Properdin deficiency associated with recurrent otitis media and pneumonia, and identification of male carrier with Klinefelter syndrome. Clin Immunol (2009) 0.90
Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. Clin Chem (2004) 0.90
Immunosuppression and risk of cervical cancer. Expert Rev Anticancer Ther (2013) 0.89
Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes. Atherosclerosis (2008) 0.89
Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort. J Autoimmun (2011) 0.89
Mannose-binding lectin deficiency is associated with myocardial infarction: the HUNT2 study in Norway. PLoS One (2012) 0.89
Genetically determined serum levels of mannose-binding lectin correlate negatively with common carotid intima-media thickness in systemic lupus erythematosus. J Rheumatol (2010) 0.88
Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke. J Neuroinflammation (2011) 0.88
A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer. J Immunol Methods (2012) 0.88
The role of properdin in zymosan- and Escherichia coli-induced complement activation. J Immunol (2012) 0.87
MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activation. Immunobiology (2009) 0.87
Quantitative proteome profiling of normal human circulating microparticles. J Proteome Res (2012) 0.87
Conventional radiography requires a MRI-estimated bone volume loss of 20% to 30% to allow certain detection of bone erosions in rheumatoid arthritis metacarpophalangeal joints. Arthritis Res Ther (2006) 0.87
Increased frequency of mannose-binding lectin insufficiency among children with acute lymphoblastic leukemia. Blood (2002) 0.86